Lytix Biopharma AS (LYTIX) — Capital Reinvestment Ratio

Latest as of September 2021: 0.00x

Lytix Biopharma AS (LYTIX) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow (Nkr138.23 Million) in capital expenditures (Nkr35.00K). See how leveraged is Lytix Biopharma AS's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

Nkr138.23 Million

NOK

Capital Expenditures

Nkr35.00K

NOK

Data as of

Sep 2021

Most recent filing

Annual Capital Reinvestment Ratio for Lytix Biopharma AS (None–None)

Year-by-year Capital Reinvestment Ratio for Lytix Biopharma AS from None to None. For live market cap and broader valuation context, see Lytix Biopharma AS (LYTIX) market capitalisation.

Year	Reinvestment Ratio	Operating CF (NOK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow